These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 1717772

  • 21. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C, Rossetti G, Vado A, Racca E, Steffenino G, Dellavalle A, Ribichini F, Ferrero V, Menardi E, Uslenghi E.
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [Abstract] [Full Text] [Related]

  • 22. Adjunctive intracoronary thrombolysis in complicated coronary angioplasty.
    Crouch MA, Nappi JM.
    Ann Pharmacother; 1997 Oct; 31(10):1244-6. PubMed ID: 9337450
    [Abstract] [Full Text] [Related]

  • 23. Percutaneous transluminal coronary angioplasty for acute myocardial infarction.
    Rothbaum DA, Hodes ZI, Linnemeier TJ, Landin RJ, Ball MW.
    Cardiol Clin; 1989 Nov; 7(4):837-51. PubMed ID: 2688885
    [Abstract] [Full Text] [Related]

  • 24. [Early reocclusion after in situ coronary desobstruction either with streptokinase or angioplasty during the acute phase of myocardial infarction].
    Puel J, Rochiccioli JP, Courtault A, Lapeyre G, Fauvel JM, Galinier M, Désandré S, Billé J, Bounhoure JP.
    Arch Mal Coeur Vaiss; 1990 Feb; 83(2):175-81. PubMed ID: 2106851
    [Abstract] [Full Text] [Related]

  • 25. Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardial infarction.
    Poloński L, Gasior M, Wasilewski J, Wilczek K, Wnek A, Adamowicz-Czoch E, Sikora J, Lekston A, Zebik T, Gierlotka M, Wojnar R, Szkodziński J, Kondys M, Szyguła-Jurkiewicz B, Wołk R, Zembala M.
    Am Heart J; 2003 May; 145(5):855-61. PubMed ID: 12766744
    [Abstract] [Full Text] [Related]

  • 26. [Coronary thrombosis--an old concept in a new light].
    Baur HR.
    Schweiz Rundsch Med Prax; 1992 Sep 22; 81(39):1147-51. PubMed ID: 1410998
    [Abstract] [Full Text] [Related]

  • 27. [Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention].
    Böger RH, Bode-Böger SM, Alfke H.
    Vasa; 1996 Sep 22; 25(1):21-31. PubMed ID: 8851262
    [Abstract] [Full Text] [Related]

  • 28. Role of new antiplatelet agents as adjunctive therapies in thrombolysis.
    Willerson JT, Golino P, McNatt J, Eidt J, Yao SK, Buja LM.
    Am J Cardiol; 1991 Jan 25; 67(3):12A-18A. PubMed ID: 1990781
    [Abstract] [Full Text] [Related]

  • 29. [Complications after treatment of acute coronary syndrome].
    Kodama K, Hirayama A.
    Nihon Rinsho; 1998 Oct 25; 56(10):2659-65. PubMed ID: 9796335
    [Abstract] [Full Text] [Related]

  • 30. Prevention and management of thrombotic complications during coronary interventions. Combination therapy with antithrombins, antiplatelets, and/or thrombolytics: risks and benefits.
    Neuhaus KL, Zeymer U.
    Eur Heart J; 1995 Nov 25; 16 Suppl L():63-7. PubMed ID: 8869021
    [Abstract] [Full Text] [Related]

  • 31. Prospects for the use of antagonists to the platelet glycoprotein IIb/IIIa receptor to prevent post-angioplasty restenosis and thrombosis.
    Ellis SG, Bates ER, Schaible T, Weisman HF, Pitt B, Topol EJ.
    J Am Coll Cardiol; 1991 May 25; 17(6 Suppl B):89B-95B. PubMed ID: 2016487
    [Abstract] [Full Text] [Related]

  • 32. Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies.
    Golino P, Willerson JT.
    Tex Heart Inst J; 1991 May 25; 18(1):50-61. PubMed ID: 15227508
    [Abstract] [Full Text] [Related]

  • 33. Dynamics of coronary thrombolysis and reocclusion.
    Becker R.
    Clin Cardiol; 1997 Nov 25; 20(11 Suppl 3):III2-5. PubMed ID: 9422855
    [Abstract] [Full Text] [Related]

  • 34. Facilitated thrombolysis: dethrombosis?
    Luciardi H, Berman S, Muntaner J, de la Serna F, Altman R.
    Clin Appl Thromb Hemost; 2002 Apr 25; 8(2):133-8. PubMed ID: 12121053
    [Abstract] [Full Text] [Related]

  • 35. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty.
    Ip JH, Fuster V, Israel D, Badimon L, Badimon J, Chesebro JH.
    J Am Coll Cardiol; 1991 May 25; 17(6 Suppl B):77B-88B. PubMed ID: 2016486
    [Abstract] [Full Text] [Related]

  • 36. [Can coronary "restenosis" after percutaneous angioplasty be prevented?].
    Juliard JM, Himbert D, Steg PG.
    Presse Med; 1992 Feb 01; 21(4):149-52. PubMed ID: 1532070
    [No Abstract] [Full Text] [Related]

  • 37. [The choice of therapy for recanalization in patients with acute myocardial infarction and the prevention of the acute reocclusion after recanalization].
    Mizuno K, Arakawa K, Shibuya T, Satomura K, Kurita A, Nakamura H.
    Jpn Circ J; 1992 Feb 01; 56 Suppl 5():1433-7. PubMed ID: 1291736
    [No Abstract] [Full Text] [Related]

  • 38. Coronary atherosclerosis: current therapeutic approaches and future trends.
    DeFeudis FV.
    Life Sci; 1991 Feb 01; 49(10):689-705. PubMed ID: 1875779
    [Abstract] [Full Text] [Related]

  • 39. Animal models of restenosis.
    Jackson CL.
    Trends Cardiovasc Med; 1994 Feb 01; 4(3):122-30. PubMed ID: 21244891
    [Abstract] [Full Text] [Related]

  • 40. [No sex differences observed in thrombolysis treatment in acute myocardial infarct but they are found in contraindications and complications].
    Zandijk E.
    Ned Tijdschr Geneeskd; 1996 Oct 05; 140(40):2008. PubMed ID: 8965932
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.